Vanguard Health Care ETF
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
236% more call options, than puts
Call options by funds: $9.46M | Put options by funds: $2.82M
42% more first-time investments, than exits
New positions opened: 119 | Existing positions closed: 84
1% more funds holding
Funds holding: 1,018 [Q3] → 1,032 (+14) [Q4]
0.43% more ownership
Funds ownership: 34.8% [Q3] → 35.23% (+0.43%) [Q4]
1% less capital invested
Capital invested by funds: $6.46B [Q3] → $6.4B (-$61.9M) [Q4]
14% less repeat investments, than reductions
Existing positions increased: 325 | Existing positions reduced: 377
19% less funds holding in top 10
Funds holding in top 10: 36 [Q3] → 29 (-7) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for VHT.
Financial journalist opinion
Based on 5 articles about VHT published over the past 30 days
Negative
Zacks Investment Research
1 week ago
Defensive ETF Strategies to Follow Amid Market Carnage
We highlight some defensive investment strategies for investors amid the ongoing chaos.
Neutral
Zacks Investment Research
2 weeks ago
Should You Invest in the Vanguard Health Care ETF (VHT)?
Launched on 01/26/2004, the Vanguard Health Care ETF (VHT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
Neutral
Invezz
2 weeks ago
Best blue-chip ETFs to buy as Donald Trump's trade war escalates
American stocks have crashed this year, and are continuing to lag behind their global peers in countries like Germany, France, and China. This performance may continue next week when Trump implements his Liberation Day tariffs, triggering a trade war.
Neutral
Seeking Alpha
3 weeks ago
VHT: Strong Growth Outlook, But Still Overpriced
Vanguard Health Care ETF (VHT) is rated a hold due to high valuations and low profitability of top holdings despite strong healthcare sector growth potential. VHT's top holdings, Eli Lilly, UnitedHealth, and AbbVie, face valuation and profitability concerns, impacting the fund's overall performance and attractiveness. Competitor funds like XLV offer lower fees and better performance, making them more appealing compared to VHT's higher expense ratio and recent negative returns.
Neutral
The Motley Fool
3 weeks ago
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Following the crowd has been disparaged quite a bit in the past. But sometimes the crowd knows what it's doing.
Negative
The Motley Fool
1 month ago
Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors
The S&P 500 (SNPINDEX: ^GSPC) is cooling off after rip-roaring gains of over 20% in both 2023 and 2024.
Neutral
Zacks Investment Research
1 month ago
5 Defensive ETF Strategies to Follow Amid Market Meltdown
We highlight some defensive investment strategies for investors amid the ongoing chaos.
Negative
Zacks Investment Research
1 month ago
Recession Fears Looming? Secure Your Portfolio With These ETFs
Look at ETFs to safeguard your portfolio as declining consumer confidence, sluggish growth and persistent inflationary pressures increase the likelihood of the U.S. economy slipping into a recession in 2025.
Positive
The Motley Fool
1 month ago
These Vanguard ETFs Show Where the Smart Money Is Moving Now
Don't discount the power of momentum. Some studies have found that momentum trading -- buying stocks or exchange-traded funds (ETFs) that are going up -- often works over the short to medium term.
Positive
The Motley Fool
1 month ago
Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025
The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market due to its scope and diversity. It measures the performance of 500 large-cap companies across all 11 stock market sectors.
Charts implemented using Lightweight Charts™